Follow
BioStock interviews BioInvent's CEO Martin Welschof and Wei-Wu He, Chairman & CEO of CASI Pharmaceuticals about their collaboration on BioInvent's propriety asset, the drug candidate and antibody BI-1206.
Repost
14
120
Please to post a comment~
Loading...
CASI-Pharmaceuticals-凯信远达
CASI Pharmaceuticals, Inc. is a NASDAQ-listed biopharmaceutical company.
View Zone